Navigation

    Forum

    • Register
    • Login
    • Search
    • Categories
    • Recent
    • Popular
    • Users
    • Groups

    Disclosure requirements of competitor names/schedules

    PAAB Code
    2
    2
    74
    Loading More Posts
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes
    Reply
    • Reply as topic
    Log in to reply
    This topic has been deleted. Only users with topic management privileges can see it.
    • palanski
      palanski last edited by

      Hi PAAB—could you kindly clarify if the below section of the code applies solely to the manufacturer's product or all products mentioned within an APS? Does this vary if the manufacturer opts to include the brand name of another manufacturer's product within an APS, not just its generic name (assume this is permissible due to an acceptable head-to-head trial)?

      2.2 In all APS for pharmaceutical products, the brand or trade name, the non-proprietary or generic name and the Federal drug schedule of the product must appear in juxtaposition at least once within advertising copy and must be in good contrast and be legible.
      
      Jennifer Carroll 1 Reply Last reply Reply Quote 1
      • Jennifer Carroll
        Jennifer Carroll @palanski last edited by

        Hello @palanski

        PAAB Code s2.2 pertains only to the promoted product(s). There are separate code sections that relate to other products (e.g., acknowledgement of trademarks where relevant). The sponsor’s legal department can help you ensure that you are meeting legal disclosure requirements for those other products.

        1 Reply Last reply Reply Quote 1
        • First post
          Last post